Al Robichaud
Private Equity Investor chez Cure Ventures Management LP
Fortune : 3 M $ au 31/03/2024
Profil
Albert J.
Robichaud is currently a Partner at Cure Ventures Management LP since 2024.
Previously, he was the Chief Scientific Officer at SAGE Therapeutics, Inc. from 2011 to 2023, and held positions as Senior Director & Head-Neuroscience Discovery at Wyeth Research from 2002 to 2010, and VP-Chemistry & Pharmacokinetic Sciences at Lundbeck, Inc. from 2010 to 2011.
He also worked as VP-Chemistry & Pharmacokinetic Sciences at Lundbeck USA Inc. Additionally, he received an undergraduate degree from Rensselaer Polytechnic Institute and a doctorate degree from the University of California, Irvine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SAGE THERAPEUTICS, INC.
0,24% | 13/02/2023 | 145 553 ( 0,24% ) | 3 M $ | 31/03/2024 |
Postes actifs de Al Robichaud
| Sociétés | Poste | Début |
|---|---|---|
Cure Ventures Management LP
 Cure Ventures Management LP Investment ManagersFinance Cure Ventures Management LP (Cure Ventures) is a venture capital firm founded in 2021 by David R Fallace, Richard J Lim and Lou A Tartaglia. The firm is headquartered in Boston, Massachusetts. | Private Equity Investor | 01/01/2024 |
Anciens postes connus de Al Robichaud
| Sociétés | Poste | Fin |
|---|---|---|
| SAGE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 09/10/2023 |
Lundbeck, Inc.
 Lundbeck, Inc. Pharmaceuticals: MajorHealth Technology Part of Lundbeck Foundation, Lundbeck, Inc. is a pharmaceutical company that produces pharmaceutical preparations. The private company is based in Paramus, NJ. The company was founded by Jeffrey S. Aronin. | Corporate Officer/Principal | 01/01/2011 |
Wyeth Research
 Wyeth Research Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Wyeth Research discovers and develops platforms encompassing pharmaceuticals. The private company is based in Cambridge, MA. | Director/Board Member | 01/01/2010 |
| Lundbeck USA Inc. | Corporate Officer/Principal | - |
Formation de Al Robichaud
| Rensselaer Polytechnic Institute | Undergraduate Degree |
| University of California, Irvine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SAGE THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Wyeth Research
Wyeth Research Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Wyeth Research discovers and develops platforms encompassing pharmaceuticals. The private company is based in Cambridge, MA. | Commercial Services |
Lundbeck, Inc.
Lundbeck, Inc. Pharmaceuticals: MajorHealth Technology Part of Lundbeck Foundation, Lundbeck, Inc. is a pharmaceutical company that produces pharmaceutical preparations. The private company is based in Paramus, NJ. The company was founded by Jeffrey S. Aronin. | Health Technology |
| Lundbeck USA Inc. | |
Cure Ventures Management LP
Cure Ventures Management LP Investment ManagersFinance Cure Ventures Management LP (Cure Ventures) is a venture capital firm founded in 2021 by David R Fallace, Richard J Lim and Lou A Tartaglia. The firm is headquartered in Boston, Massachusetts. | Finance |
